Marimed (MRMD) Consolidated Net Income (2011 - 2026)

Marimed (MRMD) has reported Consolidated Net Income for 16 consecutive years, with -$3.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Consolidated Net Income fell 155.99% year-over-year to -$3.6 million in Q2 2026; TTM through Jun 2026 was -$14.9 million, a 7.49% increase from a year earlier, with the FY2025 full-year figure at -$14.5 million, down 16.3% from the prior year.
• Consolidated Net Income was -$3.6 million for Q2 2026 at Marimed, up from -$3.8 million in the prior quarter.
• Over five years, Consolidated Net Income peaked at $4.7 million in Q4 2022 and troughed at -$10.1 million in Q4 2023.
• A 5-year average of -$2.0 million and a median of -$1.5 million in 2024 frame the typical range for Consolidated Net Income.
• Across the five-year window, Consolidated Net Income jumped 174.13% in 2022 and sank 324.07% in 2025, its largest moves.
• Over 5 years, Consolidated Net Income stood at $4.7 million in 2022, then plunged by 313.5% to -$10.1 million in 2023, then climbed by 18.49% to -$8.3 million in 2024, then surged by 43.84% to -$4.6 million in 2025, then grew by 23.06% to -$3.6 million in 2026.
• The last three Consolidated Net Income figures came in at -$3.6 million (Q2 2026), -$3.8 million (Q1 2026), and -$4.6 million (Q4 2025), per Business Quant data.